Over the past 50 years, the percentage of the Down syndrome population aged 50 and older quadrupled from about 5% to nearly 20% of the population by 2020. Alzheimer's disease prevalence is roughly six ...
Annovis is at the forefront, testing buntanetap in pivotal clinical trials as a therapy for Alzheimer's and Parkinson's diseases (PD). Company has filed three new patents protecting combinations of ...
Alzheimer's disease (AD) has become a focal point in the pharmaceutical industry as recent drugs such as Leqembi and Kisunla have received ...
Hosted on MSN7h
Tackling 14 risk factors could prevent or delay nearly half of dementia cases, study revealsThe EU's medicine watchdog recently declined to approve lecanemab and is still reviewing donanemab. These Alzheimer's treatments, approved in the US last year and developed by Biogen and Eli Lilly, ...
The attack, which ended shortly after it began, capped a chaotic 24-hour period that began with Israel’s invading of Lebanon in pursuit of Hezbollah. Iran fired a barrage of ballistic missiles ...
The Australian Red Cross says demand for blood is at a 12-year high as it launches the trial of a new pop-up donor centre in regional Western Australia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback